| Dr Stephen R Burton, MD | |
|
1400 E Downing St, Tahlequah, OK 74464-3324 | |
| (918) 456-0641 | |
| Not Available |
| Full Name | Dr Stephen R Burton |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 40 Years |
| Location | 1400 E Downing St, Tahlequah, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497735740 | NPI | - | NPPES |
| 392140 | Medicaid | SC | |
| 4673830 | Medicaid | MI |
| Facility Name | Location | Facility Type |
|---|---|---|
| Parkview Regional Medical Center | Fort wayne, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health And Services Oregon | 0648183608 | 1328 |
| Providence Medical Institute | 5991609737 | 290 |
| Providence Health And Services Mt | 6608786306 | 272 |
| Providence Health And Services Washington | 6709782600 | 393 |
| Parkview Health System Inc | 2163336967 | 1167 |
News Archive
Johns Hopkins scientists have developed a way to study the earliest steps of human blood development using human embryonic stem cells grown in a lab dish instead of the embryos themselves.
Ziehm Imaging, leading developer, manufacturer and supplier of mobile C-arms, presents its innovative, award-winning product portfolio at RSNA 2011. Latest market analyst reports (GIA[1]) predict substantial growth for the fluoroscopy and mobile C-arm market segments that will be substantially driven by the growing number of minimally invasive procedures.
Patients could be saved millions of trips to their GP under a new scheme that has the potential to revolutionise the system of prescribing medicines.
If she loves you and then she loves you not, don't blame the petals of that daisy. Blame evolution.
Merck, known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd., announced today that they have expanded their collaboration with an agreement to develop, manufacture and commercialize MK-1293, an insulin glargine candidate for the treatment of patients with type 1 and type 2 diabetes. Phase III clinical studies in type 1 and type 2 diabetes will begin soon.
› Verified 4 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164623401 PECOS PAC ID: 0648183608 Enrollment ID: O20190814001020 |
News Archive
Johns Hopkins scientists have developed a way to study the earliest steps of human blood development using human embryonic stem cells grown in a lab dish instead of the embryos themselves.
Ziehm Imaging, leading developer, manufacturer and supplier of mobile C-arms, presents its innovative, award-winning product portfolio at RSNA 2011. Latest market analyst reports (GIA[1]) predict substantial growth for the fluoroscopy and mobile C-arm market segments that will be substantially driven by the growing number of minimally invasive procedures.
Patients could be saved millions of trips to their GP under a new scheme that has the potential to revolutionise the system of prescribing medicines.
If she loves you and then she loves you not, don't blame the petals of that daisy. Blame evolution.
Merck, known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd., announced today that they have expanded their collaboration with an agreement to develop, manufacture and commercialize MK-1293, an insulin glargine candidate for the treatment of patients with type 1 and type 2 diabetes. Phase III clinical studies in type 1 and type 2 diabetes will begin soon.
› Verified 4 days ago
| Entity Name | Providence Health & Services - Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922259738 PECOS PAC ID: 2860552973 Enrollment ID: O20190823000710 |
News Archive
Johns Hopkins scientists have developed a way to study the earliest steps of human blood development using human embryonic stem cells grown in a lab dish instead of the embryos themselves.
Ziehm Imaging, leading developer, manufacturer and supplier of mobile C-arms, presents its innovative, award-winning product portfolio at RSNA 2011. Latest market analyst reports (GIA[1]) predict substantial growth for the fluoroscopy and mobile C-arm market segments that will be substantially driven by the growing number of minimally invasive procedures.
Patients could be saved millions of trips to their GP under a new scheme that has the potential to revolutionise the system of prescribing medicines.
If she loves you and then she loves you not, don't blame the petals of that daisy. Blame evolution.
Merck, known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd., announced today that they have expanded their collaboration with an agreement to develop, manufacture and commercialize MK-1293, an insulin glargine candidate for the treatment of patients with type 1 and type 2 diabetes. Phase III clinical studies in type 1 and type 2 diabetes will begin soon.
› Verified 4 days ago
| Entity Name | Providence Health & Services- Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093956278 PECOS PAC ID: 1557408176 Enrollment ID: O20190826003348 |
News Archive
Johns Hopkins scientists have developed a way to study the earliest steps of human blood development using human embryonic stem cells grown in a lab dish instead of the embryos themselves.
Ziehm Imaging, leading developer, manufacturer and supplier of mobile C-arms, presents its innovative, award-winning product portfolio at RSNA 2011. Latest market analyst reports (GIA[1]) predict substantial growth for the fluoroscopy and mobile C-arm market segments that will be substantially driven by the growing number of minimally invasive procedures.
Patients could be saved millions of trips to their GP under a new scheme that has the potential to revolutionise the system of prescribing medicines.
If she loves you and then she loves you not, don't blame the petals of that daisy. Blame evolution.
Merck, known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd., announced today that they have expanded their collaboration with an agreement to develop, manufacture and commercialize MK-1293, an insulin glargine candidate for the treatment of patients with type 1 and type 2 diabetes. Phase III clinical studies in type 1 and type 2 diabetes will begin soon.
› Verified 4 days ago
| Entity Name | Providence Medical Institute |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760425862 PECOS PAC ID: 5991609737 Enrollment ID: O20190903003192 |
News Archive
Johns Hopkins scientists have developed a way to study the earliest steps of human blood development using human embryonic stem cells grown in a lab dish instead of the embryos themselves.
Ziehm Imaging, leading developer, manufacturer and supplier of mobile C-arms, presents its innovative, award-winning product portfolio at RSNA 2011. Latest market analyst reports (GIA[1]) predict substantial growth for the fluoroscopy and mobile C-arm market segments that will be substantially driven by the growing number of minimally invasive procedures.
Patients could be saved millions of trips to their GP under a new scheme that has the potential to revolutionise the system of prescribing medicines.
If she loves you and then she loves you not, don't blame the petals of that daisy. Blame evolution.
Merck, known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd., announced today that they have expanded their collaboration with an agreement to develop, manufacture and commercialize MK-1293, an insulin glargine candidate for the treatment of patients with type 1 and type 2 diabetes. Phase III clinical studies in type 1 and type 2 diabetes will begin soon.
› Verified 4 days ago
| Entity Name | Providence Health & Services- Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124270715 PECOS PAC ID: 8325100480 Enrollment ID: O20200327001316 |
News Archive
Johns Hopkins scientists have developed a way to study the earliest steps of human blood development using human embryonic stem cells grown in a lab dish instead of the embryos themselves.
Ziehm Imaging, leading developer, manufacturer and supplier of mobile C-arms, presents its innovative, award-winning product portfolio at RSNA 2011. Latest market analyst reports (GIA[1]) predict substantial growth for the fluoroscopy and mobile C-arm market segments that will be substantially driven by the growing number of minimally invasive procedures.
Patients could be saved millions of trips to their GP under a new scheme that has the potential to revolutionise the system of prescribing medicines.
If she loves you and then she loves you not, don't blame the petals of that daisy. Blame evolution.
Merck, known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd., announced today that they have expanded their collaboration with an agreement to develop, manufacture and commercialize MK-1293, an insulin glargine candidate for the treatment of patients with type 1 and type 2 diabetes. Phase III clinical studies in type 1 and type 2 diabetes will begin soon.
› Verified 4 days ago
| Entity Name | Providence Health & Services Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194099390 PECOS PAC ID: 0345139929 Enrollment ID: O20200413000199 |
News Archive
Johns Hopkins scientists have developed a way to study the earliest steps of human blood development using human embryonic stem cells grown in a lab dish instead of the embryos themselves.
Ziehm Imaging, leading developer, manufacturer and supplier of mobile C-arms, presents its innovative, award-winning product portfolio at RSNA 2011. Latest market analyst reports (GIA[1]) predict substantial growth for the fluoroscopy and mobile C-arm market segments that will be substantially driven by the growing number of minimally invasive procedures.
Patients could be saved millions of trips to their GP under a new scheme that has the potential to revolutionise the system of prescribing medicines.
If she loves you and then she loves you not, don't blame the petals of that daisy. Blame evolution.
Merck, known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd., announced today that they have expanded their collaboration with an agreement to develop, manufacture and commercialize MK-1293, an insulin glargine candidate for the treatment of patients with type 1 and type 2 diabetes. Phase III clinical studies in type 1 and type 2 diabetes will begin soon.
› Verified 4 days ago
| Entity Name | Providence Health & Services Mt |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215222617 PECOS PAC ID: 6608786306 Enrollment ID: O20200917000431 |
News Archive
Johns Hopkins scientists have developed a way to study the earliest steps of human blood development using human embryonic stem cells grown in a lab dish instead of the embryos themselves.
Ziehm Imaging, leading developer, manufacturer and supplier of mobile C-arms, presents its innovative, award-winning product portfolio at RSNA 2011. Latest market analyst reports (GIA[1]) predict substantial growth for the fluoroscopy and mobile C-arm market segments that will be substantially driven by the growing number of minimally invasive procedures.
Patients could be saved millions of trips to their GP under a new scheme that has the potential to revolutionise the system of prescribing medicines.
If she loves you and then she loves you not, don't blame the petals of that daisy. Blame evolution.
Merck, known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd., announced today that they have expanded their collaboration with an agreement to develop, manufacture and commercialize MK-1293, an insulin glargine candidate for the treatment of patients with type 1 and type 2 diabetes. Phase III clinical studies in type 1 and type 2 diabetes will begin soon.
› Verified 4 days ago
| Entity Name | Providence Health & Services Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174744304 PECOS PAC ID: 6709782600 Enrollment ID: O20210113000803 |
News Archive
Johns Hopkins scientists have developed a way to study the earliest steps of human blood development using human embryonic stem cells grown in a lab dish instead of the embryos themselves.
Ziehm Imaging, leading developer, manufacturer and supplier of mobile C-arms, presents its innovative, award-winning product portfolio at RSNA 2011. Latest market analyst reports (GIA[1]) predict substantial growth for the fluoroscopy and mobile C-arm market segments that will be substantially driven by the growing number of minimally invasive procedures.
Patients could be saved millions of trips to their GP under a new scheme that has the potential to revolutionise the system of prescribing medicines.
If she loves you and then she loves you not, don't blame the petals of that daisy. Blame evolution.
Merck, known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd., announced today that they have expanded their collaboration with an agreement to develop, manufacture and commercialize MK-1293, an insulin glargine candidate for the treatment of patients with type 1 and type 2 diabetes. Phase III clinical studies in type 1 and type 2 diabetes will begin soon.
› Verified 4 days ago
| Entity Name | Swedish Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689612954 PECOS PAC ID: 0244138196 Enrollment ID: O20230206001431 |
News Archive
Johns Hopkins scientists have developed a way to study the earliest steps of human blood development using human embryonic stem cells grown in a lab dish instead of the embryos themselves.
Ziehm Imaging, leading developer, manufacturer and supplier of mobile C-arms, presents its innovative, award-winning product portfolio at RSNA 2011. Latest market analyst reports (GIA[1]) predict substantial growth for the fluoroscopy and mobile C-arm market segments that will be substantially driven by the growing number of minimally invasive procedures.
Patients could be saved millions of trips to their GP under a new scheme that has the potential to revolutionise the system of prescribing medicines.
If she loves you and then she loves you not, don't blame the petals of that daisy. Blame evolution.
Merck, known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd., announced today that they have expanded their collaboration with an agreement to develop, manufacture and commercialize MK-1293, an insulin glargine candidate for the treatment of patients with type 1 and type 2 diabetes. Phase III clinical studies in type 1 and type 2 diabetes will begin soon.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stephen R Burton, MD 1 Independence Pt, Suite 212, Greenville, SC 29615-4545 Ph: (864) 797-6328 | Dr Stephen R Burton, MD 1400 E Downing St, Tahlequah, OK 74464-3324 Ph: (918) 456-0641 |
News Archive
Johns Hopkins scientists have developed a way to study the earliest steps of human blood development using human embryonic stem cells grown in a lab dish instead of the embryos themselves.
Ziehm Imaging, leading developer, manufacturer and supplier of mobile C-arms, presents its innovative, award-winning product portfolio at RSNA 2011. Latest market analyst reports (GIA[1]) predict substantial growth for the fluoroscopy and mobile C-arm market segments that will be substantially driven by the growing number of minimally invasive procedures.
Patients could be saved millions of trips to their GP under a new scheme that has the potential to revolutionise the system of prescribing medicines.
If she loves you and then she loves you not, don't blame the petals of that daisy. Blame evolution.
Merck, known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd., announced today that they have expanded their collaboration with an agreement to develop, manufacture and commercialize MK-1293, an insulin glargine candidate for the treatment of patients with type 1 and type 2 diabetes. Phase III clinical studies in type 1 and type 2 diabetes will begin soon.
› Verified 4 days ago
Dr. Todd K Pogue, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1325 E Boone St, Tahlequah, OK 74464 Phone: 918-207-4977 | |
Vishal Balvantrai Jani, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1400 E Downing St, Tahlequah, OK 74464 Phone: 918-456-0641 | |
Dr. Harold M Ginzburg, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 100 S Bliss Ave, Dept Of Psychiatry, Tahlequah, OK 74464 Phone: 504-858-0066 Fax: 504-613-4913 | |
Marie D. Raine, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1400 Hensley Dr, Tahlequah, OK 74464 Phone: 918-822-0050 Fax: 918-775-5526 | |
Heather Anne Jones, DO Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 16414 W 760 Rd, Tahlequah, OK 74464 Phone: 918-561-8428 | |
Dr. Sana Syed, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1400 E Downing St, Tahlequah, OK 74464 Phone: 918-453-2111 |